Summary
Manufacturers using approved external sterilisation facilities will no longer need a separate loan licence.
A new schedule sets uniform testing fees for all medical‑device testing laboratories, improving transparency.
The European Union is now recognised as a stringent regulatory jurisdiction, allowing certain devices approved there to skip some clinical investigations in India.
Overall, the changes aim to lower compliance costs, make processes clearer, and bring advanced health technology to patients faster.